SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology…
- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia- PreFree: the first CE-marked, multimodal…
The Naderi Center sees growing demand for revision rhinoplasty, with Dr. Shervin Naderi providing surgical and non-surgical solutions customized to…
ATLANTA, GEORGIA / ACCESS Newswire / October 8, 2025 / Rezolut LLC, a national leader in advanced diagnostic imaging, is…
Black Book Survey results reveal the twenty-five firms shaping the next generation of accountable care infrastructure released in orchestration with…
Study Demonstrated a Sensitivity of 100% and Specificity of 95%Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular…
TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology…
SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified…
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage…
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, PostPRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences…